|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Current assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Total Current Assets | ||||||
| Marketable securities held in Trust Account | ||||||
| Long-term prepaid insurance | ||||||
| Deferred offering costs | ||||||
| Total Assets | ||||||
| Current liabilities | ||||||
| Accounts payable and accrued expenses | ||||||
| Promissory note - related party | ||||||
| Accrued offering costs | ||||||
| Related Party | ||||||
| Total accrued offering costs | ||||||
| Advance from related party | ||||||
| Total Current Liabilities | ||||||
| Derivative liability | ||||||
| Public Rights | ||||||
| Private Warrants | ||||||
| Deferred underwriting fee | ||||||
| Total Liabilities | ||||||
| Class A ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of approximately $10.46 per share and $10.18 per share as of September 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares, value | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...